鶹Ӱ

Skip to main content

Chemotherapy made from 'caterpillar fungus' shows early promise in clinical trials

Chemotherapy is administered to a cancer patient via intravenous drip at Duke Cancer Center in Durham, N.C., on Thursday, Sept. 5, 2013. THE CANADIAN PRESS/AP-Gerry Broome Chemotherapy is administered to a cancer patient via intravenous drip at Duke Cancer Center in Durham, N.C., on Thursday, Sept. 5, 2013. THE CANADIAN PRESS/AP-Gerry Broome
Share
CANMORE, ALTA. -

An experimental cancer drug made from a molecule found in a Himalayan fungus known as “caterpillar fungus” has shown early promise as a new treatment for patients with advanced tumours in a small clinical trial.

The new chemotherapy variety, known as NUC-7738 by researchers at the University of Oxford, is made from cordycepin, first found in a parasitic fungus species called Ophiocordyceps sinensis.

Commonly known as “caterpillar fungus,” thanks to its ability to kill and mummify moth larva in the wild, the active ingredient has been used as a herbal remedy in traditional Chinese medicine for centuries.

Now, researchers at the University of Oxford, in partnership with U.K.-based biopharmaceutical company NuCana, are testing the proposed anti-cancer, anti-oxidant, and anti-inflammatory effects of the compound in a small phase one trial involving 28 patients with advanced tumours that were resistant to conventional cancer treatment.

Cordycepin, referred as 3'-deoxyadenosine (or 3'-dA), is a naturally occurring nucleoside analogue. These analogues can be used in therapeutic drugs, including antiviral products used to prevent viral replication in infected cells.

Because the naturally occurring form of cordycepin breaks down quickly in the bloodstream, researchers altered the compound to make it resistant to this process, allowing it to enter cells independently.

The latest research shows that these changes make the proposed drug’s anti-cancer properties up to 40 times more potent than cordycepin alone.

According to trial findings published in early September, the patient cohort showed “encouraging signals of anti-tumour activity and prolonged disease stabilization" when given weekly escalating doses of NUC-7738.

"These findings provide proof of concept that NUC-7738 overcomes the cancer resistance mechanisms that limit the activity of 3'-dA and support the further clinical evaluation of NUC-7738 as a novel cancer treatment,”

Once the safety of the drug has been demonstrated in Phase 1 of the trial, the researchers will begin planning for Phase 2.​ 

CTVNews.ca Top Stories

Childhood sleep issues may raise suicide risk, study finds

If your child sometimes has trouble sleeping, it may be easy to chalk it up to a phase they will grow out of one day. But a new study suggests possible serious consequences for this line of thought — such as a higher risk for suicidal ideation or attempts when they are older.

Local Spotlight

Cole Haas is more than just an avid fan of the F.W. Johnson Wildcats football team. He's a fixture on the sidelines, a source of encouragement, and a beloved member of the team.

Getting a photograph of a rainbow? Common. Getting a photo of a lightning strike? Rare. Getting a photo of both at the same time? Extremely rare, but it happened to a Manitoba photographer this week.

An anonymous business owner paid off the mortgage for a New Brunswick not-for-profit.

They say a dog is a man’s best friend. In the case of Darren Cropper, from Bonfield, Ont., his three-year-old Siberian husky and golden retriever mix named Bear literally saved his life.

A growing group of brides and wedding photographers from across the province say they have been taken for tens of thousands of dollars by a Barrie, Ont. wedding photographer.

Paleontologists from the Royal B.C. Museum have uncovered "a trove of extraordinary fossils" high in the mountains of northern B.C., the museum announced Thursday.

The search for a missing ancient 28-year-old chocolate donkey ended with a tragic discovery Wednesday.

The Royal Canadian Mounted Police is celebrating an important milestone in the organization's history: 50 years since the first women joined the force.

It's been a whirlwind of joyful events for a northern Ontario couple who just welcomed a baby into their family and won the $70 million Lotto Max jackpot last month.